Coronavirus SARS-CoV-2: nota informativa sobre el maneig de la teràpia hormonal de la menopausa i el tractament anticonceptiu en la COVID-19 [fullet]
Abstract
The aim of this paper is to describe the considerations to be considered in women treated with menopausal hormone therapy (THM) or combined hormonal contraception (AHC) in the context of a coronavirus infection or suspected infection. SARS-CoV-2 for the risk of VTE associated with these treatments.
Keywords
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Menopause; Hormone therapy; Contraceptive treatment
Bibliographic citation
Programa d’Harmonització Farmacoterapèutica. Coronavirus SARS-CoV-2: nota informativa sobre el maneig de la teràpia hormonal de la menopausa i el tractament anticonceptiu en la COVID-19 [fullet]. Barcelona: Servei Català de la Salut; 2020.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/4895This item appears in following collections
The following license files are associated with this item: